TABLE 3.
Outcome | All Subjects (n = 114) | P | Subjects on Home Respiratory Supporta | P |
---|---|---|---|---|
n | 114 | 50 | ||
Emergency department visit | 0.54 (0.16–1.86) | .33 | .022 (0.02–3.30) | .28 |
Inpatient hospitalization | 0.68 (0.17–2.73) | .58 | 0.25 (0.01–5.10) | .37 |
Systemic steroid use | 0.38 (0.07–1.91) | .24 | 0.92 (0.08–11.21) | .95 |
Antibiotic use | 0.95 (0.27–3.38) | .94 | 0.35 (0.02–6.31) | .48 |
Cough or wheeze | 1.93 (0.72–5.13) | .19 | 0.56 (0.10–3.01) | .50 |
Rescue β-agonist use | 1.48 (0.51–4.26)b | .47 | 5.19 (0.77–34.86)c | .09 |
Activity limitations | 1.25 (0.29–5.36)b | .76 | 0.69 (0.10–4.59)c | .70 |
Nighttime symptoms | 1.03 (0.36–2.97)b | .96 | 0.83 (0.12–5.75)c | .85 |
Values are presented as the adjusted OR (95% confidence interval). ORs were generated through logistic regression by using self-reported smoker residing in the home (yes/no) and adjusted for gestational age, log of estimated household income, primary caregiver education level (high school graduate or less versus some college or more), and age at the time of questionnaire completion.
Of the 50 subjects in this study on home respiratory support, 44 were on supplemental oxygen via nasal cannula, 4 were on home ventilators with supplemental oxygen entrainment, and 2 were on home ventilators without supplemental oxygen. Of these 50 subjects, 8 (16%) were self-reported as residing with a smoker.
n = 113.
n = 49.